NMN (Nicotinamide Mononucleotide)
Research Reliability -
A direct NAD+ precursor that has become the flagship molecule of the modern longevity supplement movement.
Appetite
Mood
Sleep
NMN (Nicotinamide Mononucleotide)
Description
NMN sits one enzymatic step upstream of NAD+ in the salvage pathway and has become the flagship molecule of the longevity-supplement movement championed by researchers like David Sinclair. NAD+ is required for hundreds of cellular reactions, including DNA repair via PARP enzymes and the activity of sirtuins, the so-called "longevity genes" implicated in stress resistance and metabolic health. Levels decline roughly 50% between age 20 and 60, which biohackers link to fatigue, slower recovery, and accelerated aging. NMN was excluded from the U.S. dietary supplement definition in 2022 and reinstated as lawful in September 2025, so sourcing from a reputable, third-party-tested manufacturer matters given years of inconsistent quality on the open market.
Effects
First 2 weeks
no felt effect for most
Weeks 2–4
NAD+ levels rise on testing
Long term
a longevity thesis, human outcome data still developing
How it Feels
Most people feel nothing; a subset report steadier energy over a few weeks, which is hard to separate from expectation. This is taken as a bet on NAD+ biology and aging, measured on labs rather than sensation. The long-term human evidence is still being built.
Usage
Entry Dose
250mg
Standard Dose
500–1000mg
Max Dose
1500mg
Onset
2–4 weeks (NAD+ levels)
Combinations
Pairs well with
Synergistic
Resveratrol — activates sirtuins that require NAD+ as a cofactor to function; take with a fat source
TMG (Betaine) — replenishes methyl groups consumed by NMN-to-NAD+ conversion
Pterostilbene — bioavailable resveratrol analog with similar sirtuin-activating synergy
Avoid combining
Contraindicated
Active cancer — rapidly dividing cells may also benefit from elevated NAD+ pools; theoretical concern, discuss with an oncologist
Concurrent rapamycin — some longevity researchers stagger rather than stack these pending more interaction data
Biomarkers to Track
Subjective
(Daily)
Energy and afternoon fatigue (1–10)
Exercise recovery speed
Skin and hair vitality
Objective
(Quarterly)
Whole blood NAD+ level (specialty test)
Fasting glucose and HbA1c
Grip strength (sarcopenia proxy)
Generally well tolerated in studies, but a longevity bet with human outcome data still developing. Note its regulatory status has been contested in the US.
Pregnant and breastfeeding women, and cancer patients should discuss it first.
Expecting a felt effect, and paying premium prices for unverified products.
Preliminary (limited / small human data)
NMN reliably raises NAD+ levels, but the human trial evidence for downstream clinical benefits (versus biomarker changes) remains limited. NMN's U.S. regulatory status as a dietary supplement has changed more than once in recent years; confirm current status before making supplement-category claims.
Yoshino M et al. (2021). Science, 372(6547), 1224-1229. RCT (NMN and muscle insulin sensitivity in prediabetic postmenopausal women). PMID: 33888596. DOI: 10.1126/science.abe9985.